Anti-greying research is becoming more credible because scientists can now test specific compounds against the real biology of greying.

Historically, the search for anti-greying remedies was cluttered with unproven supplements and indirect treatments. A major hurdle has always been the timeline: because true age-related greying takes decades to unfold, proving a “cure” in humans is slow and expensive.

However, our understanding of the mechanism has sharpened. Scientists can now pinpoint exactly why the system fails — from stem cell depletion to signalling breakdowns. This allows researchers to focus on high-potential biological candidates that realistically protect these pathways.

Leading this new class are specific antioxidants that help the follicle cope with stressors before damage becomes permanent.

Many antioxidants are plant-derived polyphenols and flavonoids, such as Luteolin, Hesperetin and Diosmetin, which are already used in dermatology to help shield skin from environmental damage. The logic is straightforward: if oxidative stress helps push follicle stem cells and pigment cells toward dysfunction, then targeted antioxidants might slow that drift and preserve the niches that keep hair coloured.

In line with this idea, a team from Nagoya showed in a lab model that the flavonoid Luteolin can protect melanocyte stem cells and significantly reduce age-related greying [Ref 1], making it one of the first concrete antioxidant candidates for an anti-greying remedy.

Two of the most important drivers of greying are oxidative stress and the breakdown of the local signals that keep pigment stem cells working.

Hair follicles are tiny factories. They need energy to run, and they need signals to keep all their cells coordinated while they use that energy. Those two needs map well onto two important drivers of greying: oxidative stress and breakdowns in cell signalling.

Oxidative stress is a kind of chemical “wear and tear.” During normal metabolism, and under UV light, inflammation, or pollution, cells generate highly reactive molecules called reactive oxygen species (ROS), basically chemical sparks. In small amounts they’re normal and even useful. But if too many build up and the body’s defences can’t neutralise them, they start damaging important cell parts like DNA, fats, and proteins. Over time, that damage makes cells age faster or stop working properly.

In hair follicles, oxidative stress is linked to faster wear in pigment cells and their stem cells, weaker melanin production, and a less supportive follicle environment [Ref 2].

Cell signalling issues are the other major driver. Pigment stem cells rely on short-range cues from nearby support cells to stay healthy. As those cues can weaken, and the pigment supply becomes less reliable. For the full signalling story, see Why Hair Turns Grey When Cells Stop “Talking”.

The Luteolin study sits at this intersection. It tests whether reducing oxidative stress and preserving key niche signals can keep the pigment system working for longer in a fast-greying mouse model.

Better anti-greying research required a model that greys in a trackable, human-like way. We now appear to have one.

Most mouse strains are a poor match for human greying because they rarely develop a clean, gradual salt-and-pepper fade with age. Colour change can be slow, patchy, or tied to one-off stressors, which makes it hard to tell whether a treatment is truly slowing age-related greying. But researchers can alter mouse DNA to create exactly this kind of model. That is what was achieved in RET mice by the team behind the 2020 study [Ref 3].

Crucially, RET mice start with normal dark fur and then accumulate grey hairs progressively, creating a trackable greying slope. That gives researchers a realistic way to ask whether candidates like Luteolin preserve the melanocyte stem-cell (MeSC) reserve and keep supplying pigment-producing cells cycle after cycle, delaying the visible build-up of grey hair.

In the 2020 study, the team treated these mice as a living timeline of greying [Ref 3]. They kept groups of ordinary mice and groups of RET-mice and followed them from youth into old age. At key ages, they plucked small samples of trunk hair and counted 100 hairs per mouse, classifying each one as dark or grey to calculate how the proportion of grey hairs changed over time. They also took small skin samples so they could later compare what was happening inside dark versus grey follicles. This step-by-step tracking of hair colour and follicle structure, across many ages and in both normal and RET-mice, is the backbone of the model; the next question is what they found when they started looking inside those follicles.

In this lab model, which recapitulates key steps seen in human greying, researchers tested the plant flavonoid Luteolin in two ways: applying a 1% Luteolin solution to shaved skin and administering Luteolin orally mixed into the food.

In both setups, mice that received Luteolin developed grey hairs more slowly than untreated animals. When the researchers looked at the follicles, they saw that treated mice kept more pigment stem cells and pigment-producing cells, which means the follicles could stay 'in colour mode' for longer [Ref 1].

To check if this was just any antioxidant effect, they repeated the experiment with two related flavonoids, Hesperetin and Diosmetin. Those did not slow greying and did not protect the pigment stem cells in the same way. So in this model, Luteolin stood out as the only flavonoid that clearly slowed the build-up of grey hairs.

The study suggests Luteolin delayed greying by reducing oxidative stress and preserving key niche signals that keep pigment stem cells functional. As a result, Luteolin-treated follicles retained more melanocyte stem cells and more pigment-producing melanocytes in the bulb. Overall, Luteolin appears to do more than act as a generic antioxidant in this model. It helps protect the pigment stem-cell system and slows the shift from coloured to grey hair.

The experimental result shows that Luteolin is a serious anti-greying candidate with a clear biological rationale.

In this lab model, Luteolin helped preserve the pigment “stem-cell bank” by lowering oxidative stress and keeping the follicle environment more supportive for pigment renewal.

The core building blocks of this system exist in human follicles too, which makes Luteolin a plausible candidate. Luteolin was the only compound in the study that effectively protected this system, helping pigment stem cells resist stress and continue producing colour. Confirming its full potential in humans requires well-designed clinical research.

Luteolin was not just proposed as an anti-greying candidate — it was tested in a fast-greying model, and it helped. More importantly, we have a clear idea of why. In the experiments, greying slowed because Luteolin reduced oxidative stress and improved signalling in the stem-cell niche, helping preserve the melanocyte reserve. That means it acted on key drivers of greying. As a result, even under stress exposure, treated mice stayed coloured.